Details for New Drug Application (NDA): 021057
✉ Email this page to a colleague
The generic ingredient in GANIRELIX ACETATE is ganirelix acetate. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.
Summary for 021057
Tradename: | GANIRELIX ACETATE |
Applicant: | Organon Usa Organon |
Ingredient: | ganirelix acetate |
Patents: | 0 |
Pharmacology for NDA: 021057
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Antagonists |
Physiological Effect | Decreased GnRH Secretion |
Suppliers and Packaging for NDA: 021057
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057 | NDA | Organon LLC | 78206-138 | 78206-138-01 | 1 BLISTER PACK in 1 CARTON (78206-138-01) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS |
GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057 | NDA | Organon LLC | 78206-138 | 78206-138-02 | 1 BLISTER PACK in 1 CARTON (78206-138-02) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 250MCG/0.5ML | ||||
Approval Date: | Jul 29, 1999 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 021057
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Subscribe | ⤷ Subscribe |
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Subscribe | ⤷ Subscribe |
Organon Usa Organon | GANIRELIX ACETATE | ganirelix acetate | INJECTABLE;INJECTION | 021057-001 | Jul 29, 1999 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription